EtCO2 Monitoring, Capnography Waveforms, Breathing Training
End-tidal CO2 (etCO2) monitoring or capnography has been
a valuable tool in a clinical setting for many decades (see medical reviews:
Bhende MS, LaCovey, 2001; Cambra & Pons, 2003; Zwerneman, 2006). It has been
also applied for breathing retraining. It provides additional information about
the progress of a person in their breathing normalization. Sometimes,
however, etCO2 monitoring is used as a feedback or biofeedback mechanism.
Can capnometers improve the effectiveness of breathing exercises or could it
worsen the outcomes? What is the scope of correct application of capnometers
and capnography in breathing retraining? First, let us consider expected etCO2
values in people with chronic diseases.
Minute ventilation rates (chronic diseases)
| Condition | Minute ventilation |
Number of people |
All
references or click below for abstracts |
| Normal breathing | 6 L/min | - | Medical textbooks |
| Healthy Subjects | 6-7 L/min | >400 | Results of 14 studies |
| Heart disease | 15 (±4) L/min | 22 | Dimopoulou et al, 2001 |
| Heart disease | 16 (±2) L/min | 11 | Johnson et al, 2000 |
| Heart disease | 12 (±3) L/min | 132 | Fanfulla et al, 1998 |
| Heart disease | 15 (±4) L/min | 55 | Clark et al, 1997 |
| Heart disease | 13 (±4) L/min | 15 | Banning et al, 1995 |
| Heart disease | 15 (±4) L/min | 88 | Clark et al, 1995 |
| Heart disease | 14 (±2) L/min | 30 | Buller et al, 1990 |
| Heart disease | 16 (±6) L/min | 20 | Elborn et al, 1990 |
| Pulm hypertension | 12 (±2) L/min | 11 | D'Alonzo et al, 1987 |
| Cancer | 12 (±2) L/min | 40 | Travers et al, 2008 |
| Diabetes | 12-17 L/min | 26 | Bottini et al, 2003 |
| Diabetes | 15 (±2) L/min | 45 | Tantucci et al, 2001 |
| Diabetes | 12 (±2) L/min | 8 | Mancini et al, 1999 |
| Diabetes | 10-20 L/min | 28 | Tantucci et al, 1997 |
| Diabetes | 13 (±2) L/min | 20 | Tantucci et al, 1996 |
| Asthma | 13 (±2) L/min | 16 | Chalupa et al, 2004 |
| Asthma | 15 L/min | 8 | Johnson et al, 1995 |
| Asthma | 14 (±6) L/min | 39 | Bowler et al, 1998 |
| Asthma | 13 (±4) L/min | 17 | Kassabian et al, 1982 |
| Asthma | 12 L/min | 101 | McFadden & Lyons, 1968 |
| COPD | 14 (±2) L/min | 12 | Palange et al, 2001 |
| COPD | 12 (±2) L/min | 10 | Sinderby et al, 2001 |
| COPD | 14 L/min | 3 | Stulbarg et al, 2001 |
| Sleep apnea | 15 (±3) L/min | 20 | Radwan et al, 2001 |
| Liver cirrhosis | 11-18 L/min | 24 | Epstein et al, 1998 |
| Hyperthyroidism | 15 (±1) L/min | 42 | Kahaly, 1998 |
| Cystic fibrosis | 15 L/min | 15 | Fauroux et al, 2006 |
| Cystic fibrosis | 10 L/min | 11 | Browning et al, 1990 |
| Cystic fibrosis* | 10 L/min | 10 | Ward et al, 1999 |
| CF and diabetes* | 10 L/min | 7 | Ward et al, 1999 |
| Cystic fibrosis | 16 L/min | 7 | Dodd et al, 2006 |
| Cystic fibrosis | 18 L/min | 9 | McKone et al, 2005 |
| Cystic fibrosis* | 13 (±2) L/min | 10 | Bell et al, 1996 |
| Cystic fibrosis | 11-14 L/min | 6 | Tepper et al, 1983 |
| Epilepsy | 13 L/min | 12 | Esquivel et al, 1991 |
| CHV | 13 (±2) L/min | 134 | Han et al, 1997 |
| Panic disorder | 12 (±5) L/min | 12 | Pain et al, 1991 |
| Bipolar disorder | 11 (±2) L/min | 16 | MacKinnon et al, 2007 |
| Dystrophia myotonica | 16 (±4) L/min | 12 | Clague et al, 1994 |
It is obvious that, since nearly 100% of people with chronic diseases suffer from chronic hyperventilation, they should have reduced etCO2 levels and the purpose of breathing retraining is to normalize end-tidal and alveolar CO2 levels so that to improve oxygen transport.
Capnography waveforms and etCO2 and breathing patterns
Capnography measures etCO2 and this end-tidal CO2, in conditions of normal breathing (6 L/min, 12 breaths/min, 500 ml for tidal volume) is very close to alveolar CO2. Since problems with lungs are not common and gas exchange between alveoli and the blood is very fast and effective, alveolar CO2 reflects arterial CO2. Hence, capnography can define CO2 level in the arterial blood. However, since modern people do not have normal diaphragmatic breathing at rest, etCO2 can be misleading due to various factors.
The
first problem with etCO2 monitoring relates to chest breathing. During
normal diaphragmatic breathing (the top capnography waveforms graph), we get a nice alveolar
plateau. As a result, it is easy to find the alveolar CO2 pressure that
corresponds to the top of this plateau. (In this case, the alveolar CO2 is
about 5% or 38 mm Hg, which is common for some modern normals.)
Chest breathing leads to abnormally high etCO2 readings due to inhomogeneous (or uneven) lung ventilation. As the lower capnography waveforms show, there is no plateau since the last part of the exhalation has the gas coming from the CO2-rich bottom of the lungs, and it is hard to tell what is the real alveolar CO2. (As you can see on the graph, the etCO2 is the same or about 5% or 38 mm Hg, but respiratory frequency is higher: about 15 breaths/min instead of 12.)
From the physiological viewpoint, if we compare these 2 breathing patterns, the normal breathing pattern (the top capnography waveforms graph) and chest breathing with hyperventilation (the lower capnography waveforms graph), chest breathing may have both reduced arterial CO2 and reduced arterial O2 tensions due to hyperventilation with ventilation/perfusion mismatch. (Heavy breathing still removes too much CO2, but uneven gas exchange compromises blood oxygenation.)
Capnography waveforms and end tidal CO2
biofeedback monitoring during breathing exercises
If a person breath holds, his etCO2 reading is going to show zero (no CO2
exhaled). Obviously, his alveolar and arterial CO2 values increase during breath holding. If the
person has a very shallow breathing pattern (with the tidal volume as his dead
space or about 200-250 ml), there would be almost no gas exchange (very
limited gas exchange will take place due to diffusion). Hence, his capnography
end-tidal CO2 pressure will be small, but the alveolar and arterial CO2
pressures will be much greater and increasing in time.
Hence, any changes in breathing patterns, as during breathing exercises and
any other dynamic situations, should be analyzed with caution.
This effect could be also understood from the viewpoint of CO2 accumulation. If a person holds his breath, his body accumulates CO2 and etCO2 is going to be zero. If a person performs a Buteyko reduced breathing exercise (breathing about 15-20 less air with reduced minute ventilation), it will take several minutes before stable CO2 values will be shown by the capnometer since large amounts of CO2 can be dissolved in the blood, and intra- and extra-cellular fluids. Hence, it will take several minutes (up to 5-7 min) for the stable waveforms to appear. Would etCO2 represent arterial CO2?
Let us look in more detail. If the person practices Buteyko reduced breathing exercise with strong air hunger (both minute ventilation and tidal volume are reduced about 2 times), end tidal CO2 monitoring is not going to reflect the alveolar CO2 concentration. Physiological studies have also found that people with larger tidal volume and reduced respiratory frequency have abnormally high etCO2 values. Since reduced breathing in the sick (less than 20 s for the body oxygen test or more than 12 L/min for minute ventilation at rest) is done with increased respiratory frequency and reduced tidal volume, they can get low etCO2 numbers, while in reality their alveolar and arterial CO2 will be increasing during the whole session (e.g., 10-15 minutes).
Vice versa, if a person starts a deep breathing exercise with increased minute ventilation with deliberate extended exhalations (to push all high-CO2 air out from the lungs), their etCO2 capnography monitoring will show increased etCO2 levels, while alveolar and arterial CO2 concentrations will be less and less.
Indeed,
medical doctors also observed these dynamic effects in during anesthesia.
A large review of medical literature resulted in an article "Misleading
end-tidal CO2 tensions" (Wahba & Tessler, 1996). The authors wrote, "End-tidal
PCO2 is often not indicative of PaCO2. Also, changes in PETCO2 do not always
accurately indicate the direction and extent of the change in PaCO2."
They explained that "... hemodynamic instability have an increased
Pa-PETCO2 gradient".
Finally, there are purely psychological factors that can seriously distort etCO2 capnography results. When someone holds a capnometer under your nose, it is difficult to maintain the automatic breathing pattern. Our breathing parameters undergo large changes as soon as we pay attention to our breath.
For example, most Buteyko breathing students, since they know that hyperventilation is not good and they practiced the reduced breathing hundreds of times in the past, may start reducing breathing as soon as there is something under their nose. (Many Buteyko teachers even say to their students, "Japanese samurai had a feather under their nose for 1 hour every day to train their breath. The goal was to have this feather motionless." Hence, the capnometer could immediately trigger this image.)
Other
people may have a fantasy about the importance of deep breathing and they
may start practicing deep breathing as soon as someone holds a device under
their nose.
The effects will be opposite: the Buteyko student will get abnormally low etCO2 (and higher arterial CO2), while a "deep breather" will get abnormally high etCO2 with reduced arterial CO2 concentrations.
Hence, etCO2 monitoring and capnography are not useful as biofeedback, but can be used in the long run (e.g., once per day or once per week), as an additional tool for breathing retraining control. This is exactly how Dr. Buteyko viewed and described capnography monitoring in his patents and other writings.
The situation with breathing devices is different since the practicing person has to have large diaphragmatic inhalations and exhalations, while the capnometer can be used to measure CO2 inside the breathing device or near the place where air flow leaves the device. In this application (e.g., for the Frolov breathing device therapy), the results will show real CO2 values in the container at the end of exhalations and etCO2 monitoring and capnography waveforms can be used as biofeedback.
Warning.
There are numerous restrictions and contraindications for some
health problems (anxiety, diabetes, hypertension, GI problems, and so on) in
relation to specific breathing exercises. In addition, pregnant women, people
with organ transplants, and some other groups of people should follow special guidelines
in relation to their general breathing retraining progress. Finally, there are important
preliminary requirements that make breath work safe and more effective (empty stomach,
good thermoregulation, and so forth). All these factors can be found
in the Learning Section of this website.
Reference Web Pages: Breathing norms, Medical Graphs and Tables about Breathing Rates (Minute Ventilation) and
Body Oxygen in Healthy, Normal and Sick People
Breathing
norms Parameters, graph, and description of the normal
breathing pattern
6 breathing myths 6
myths about breathing and body oxygenation (prevalence: over 90%)
Hyperventilation Definitions of
hyperventilation: their advantages and weak points
Hyperventilation Syndrome in the
Sick. Table
1. Western scientific evidence about prevalence of CHV
(chronic hyperventilation) in patients with various chronic conditions
(34 medical studies)
Normal Minute Ventilation in
Healthy Subjects: Easy and Light Breathing (14 Studies)
Hyperventilation Prevalence Present in Over 90% of
Normal People (24 medical publications)
HV and hypoxia
How and why deep breathing reduces oxygenation of cells and tissues of
all vital organs
Body oxygen test
How to measure your own breathing and body oxygenation (a simple DIY test)
Body oxygen in healthy
Table 4. CP (body oxygen level) in healthy people (27 medical
studies)
Body oxygen in sick Table 5.
CP (body oxygen level) in sick people (14 medical studies)
Buteyko
Table of Health Zones with clinical description of most common zones
Morning HV Morning
hyperventilation effect or how and why critically ill people are most
likely to die during early morning hours
References: CO2 Effects Web Pages
Vasodilation: CO2 expands arteries and arterioles facilitating perfusion
(or blood
supply) to all vital organs
The Bohr effect
How and why oxygen is released by red blood cells in tissues
Cell Oxygen Levels and oxygen transport are controlled by
alveolar CO2 and breathing
Oxygen Transport depends on
breathing and these two effects (Vasoconstriction-Vasodilation and the Bohr
effect) are parts of two diagrams that summarize influences of hypocapnia (low CO2
content in the blood and cells) on circulation and O2 delivery
Free Radical Generation takes
place due to anaerobic cell respiration caused by cell hypoxia. Hence,
antioxidant defenses of the human body are also regulated by CO2 and breathing
Inflammatory Response is controlled by
breathing since hypoxia leads to or intensifies chronic inflammation through over-expression
of the hypoxia-inducible factor 1, while normal
breathing reduces these processes
Nerve stabilization takes place due to calmative or
sedative effects of carbon dioxide in neurons or nerve cells
Muscle relaxation or relaxation of muscle cells
is normal at high CO2, while hypocapnia causes muscular tension, poor posture
and, sometimes, aggression and violence
Brochodilation - dilation of
airways (bronchi and bronchioles) by carbon dioxide, and their constriction due
to hypocapnia
Blood
pH regulation and regulation of other bodily fluids
CO2: Lung Damage Healer: Elevated carbon
dioxide prevents injury and promotes healing of lung tissues
CO2: Skin and Tissue Healer
Synthesis of Glutamine
in the Brain, CO2 fixation, and other chemical reactions
CO2 myth
"CO2 is a toxic waste gas" myth
Breathing control
How is our breathing regulated? Why hypocapnia makes breathing uneven and erratic
Go back to Breathing Techniques
| Disclaimer | Copyright © 2011 Artour Rakhimov | About Artour | Contributions | Contact details | Promote this site |
